Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Methotrexate | 10 | uM | 2 | 625.00 | 277.50 | 958.33 | 3384.25 | 0.2940 | 0.3925 |
| MCF 10A | Taxol | 0.00016596 | uM | 2 | 625.00 | 277.50 | 3069.67 | 3384.25 | 0.9003 | 0.9265 |
| MCF 10A | Taxol | 0.00033113 | uM | 2 | 625.00 | 277.50 | 4042.67 | 3384.25 | 1.2077 | 1.1026 |
| MCF 10A | Taxol | 0.001 | uM | 2 | 625.00 | 277.50 | 1488.33 | 3384.25 | 0.4395 | 0.5912 |
| MCF 10A | Taxol | 0.0031623 | uM | 2 | 625.00 | 277.50 | 506.33 | 3384.25 | 0.1529 | 0.1732 |
| MCF 10A | Taxol | 0.01 | uM | 2 | 625.00 | 277.50 | 220.00 | 3384.25 | 0.0662 | -0.0636 |
| MCF 10A | Taxol | 0.031623 | uM | 2 | 625.00 | 277.50 | 276.67 | 3384.25 | 0.0824 | -0.0007 |
| MCF 10A | Taxol | 0.1 | uM | 2 | 625.00 | 277.50 | 198.00 | 3384.25 | 0.0596 | -0.0906 |
| MCF 10A | Taxol | 0.31623 | uM | 2 | 625.00 | 277.50 | 256.00 | 3384.25 | 0.0756 | -0.0240 |
| MCF 10A | Taxol | 1 | uM | 2 | 625.00 | 277.50 | 246.67 | 3384.25 | 0.0735 | -0.0326 |
| MCF 10A | Etoposide | 0.0033113 | uM | 2 | 625.00 | 277.50 | 4298.67 | 4163.75 | 1.0325 | 1.0159 |
| MCF 10A | Etoposide | 0.01 | uM | 2 | 625.00 | 277.50 | 3871.33 | 4163.75 | 0.9329 | 0.9635 |
| MCF 10A | Etoposide | 0.031623 | uM | 2 | 625.00 | 277.50 | 3719.33 | 4163.75 | 0.9021 | 0.9457 |
| MCF 10A | Etoposide | 0.1 | uM | 2 | 625.00 | 277.50 | 3249.67 | 4163.75 | 0.7787 | 0.8733 |
| MCF 10A | Etoposide | 0.31623 | uM | 2 | 625.00 | 277.50 | 845.33 | 4163.75 | 0.2009 | 0.3190 |
| MCF 10A | Etoposide | 1 | uM | 2 | 625.00 | 277.50 | 300.33 | 4163.75 | 0.0716 | 0.0155 |
| MCF 10A | Etoposide | 3.1623 | uM | 2 | 625.00 | 277.50 | 161.33 | 4163.75 | 0.0392 | -0.1329 |
| MCF 10A | Etoposide | 10 | uM | 2 | 625.00 | 277.50 | 161.33 | 4163.75 | 0.0385 | -0.1350 |
| MCF 10A | Etoposide | 19.9526 | uM | 2 | 625.00 | 277.50 | 155.33 | 4163.75 | 0.0369 | -0.1433 |
| MCF 10A | Nilotinib | 0.0033113 | uM | 2 | 625.00 | 277.50 | 4118.67 | 4163.75 | 0.9857 | 0.9871 |
| MCF 10A | Nilotinib | 0.01 | uM | 2 | 625.00 | 277.50 | 4499.00 | 4163.75 | 1.0806 | 1.0390 |
| MCF 10A | Nilotinib | 0.031623 | uM | 2 | 625.00 | 277.50 | 4904.00 | 4163.75 | 1.1871 | 1.0884 |
| MCF 10A | Nilotinib | 0.1 | uM | 2 | 625.00 | 277.50 | 4894.33 | 4163.75 | 1.1681 | 1.0783 |
| MCF 10A | Nilotinib | 0.31623 | uM | 2 | 625.00 | 277.50 | 4628.67 | 4163.75 | 1.1221 | 1.0568 |
| MCF 10A | Nilotinib | 1 | uM | 2 | 625.00 | 277.50 | 4732.67 | 4163.75 | 1.1398 | 1.0683 |